Overview
Tekton Research played a pivotal role in advancing a recent Alzheimer’s Disease clinical trial, demonstrating exceptional performance across enrollment, site readiness, and strategic consultation. Our team not only enrolled the study’s first patient but also exceeded initial recruitment expectations, delivering high-quality data while supporting a newly engaged Principal Investigator (PI) through our robust training and onboarding program.
Key Achievements
Key Metrics
Goal: 10 | Enrolled: 11
First Patient Enrolled: Tekton led enrollment by randomizing the first patient in the study—setting the pace for the trial.
Enrollment Goal Surpassed: Initially tasked with enrolling 10 participants, our team was asked to increase enrollment due to our strong performance. Ultimately, we enrolled 11 patients, becoming one of the top enrollers in the study.
Top Enrolling Site: Our success in exceeding enrollment targets helped accelerate study timelines and ensure robust data collection for the sponsor.
Protocol Consultation: Tekton was invited to consult on study design and implementation, contributing operational insights that improved study feasibility and site preparedness.
First-Time PI Success: This trial was led by a new-to-Tekton Principal Investigator, whose successful participation highlights the strength of Tekton’s proven onboarding and training process. Our site team provided hands-on support, enabling the PI to contribute meaningful clinical insights while maintaining regulatory compliance and study protocol fidelity.
Conclusion
This Alzheimer's Disease study exemplifies Tekton Research’s commitment to clinical excellence, operational agility, and collaborative execution. From enrolling the first patient to exceeding recruitment goals and empowering investigators, Tekton continues to deliver high-impact results that move science forward.
